Ignite Creation Date:
2024-05-06 @ 7:00 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05861479
Status:
COMPLETED
Last Update Posted:
2023-05-17
First Post:
2023-05-05
Brief Title:
Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Assessment of the Prognostic Value of the Estimation of Plasma Volume or Its Variation in Patients With Pulmonary Arterial Hypertension PAH or Chronic Thromboembolic Pulmonary Hypertension CTEPH After Acute Right Heart Failure
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assessment of the prognostic value of the estimation of plasma volume or its variation in patients with pulmonary arterial hypertension PAH or chronic thromboembolic pulmonary hypertension CTEPH after acute right heart failure
Detailed Description:
The aim of the study is to show that a low plasma volume status assessed by the Strauss estimated plasma volume variation and the Duarte instantaneous estimated plasma volume formulas evaluated during acute right heart failure in patients presenting with PAH or CTEPH is associated with better long-term outcomes
Optimization of plasma volume is important for patients with PAH and CTEPH and constitutes a prognostic factor However plasma volume status can be difficult to assess in clinical practice Different formulas have been developed and have shown interest in patients with congestive heart failure with an association between plasma volume estimation and long-term prognosis
Acute right heart failure may occur in patients with PAH and CTEPH Thus the investigators plan to study the prognostic value of these formulas evaluating plasma volume in patients with PAH or CTEPH after acute right heart failure
Optimization of plasma volume is important for patients with PAH and CTEPH and constitutes a prognostic factor However plasma volume status can be difficult to assess in clinical practice Different formulas have been developed and have shown interest in patients with congestive heart failure with an association between plasma volume estimation and long-term prognosis
Acute right heart failure may occur in patients with PAH and CTEPH Thus the investigators plan to study the prognostic value of these formulas evaluating plasma volume in patients with PAH or CTEPH after acute right heart failure
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None